PMID- 2893373 OWN - NLM STAT- MEDLINE DCOM- 19880302 LR - 20190501 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 85 IP - 1 DP - 1988 Jan TI - An extended HLA-D region haplotype associated with celiac disease. PG - 222-6 AB - Celiac disease has one of the strongest associations with HLA (human leukocyte antigen) class II markers of the known HLA-linked diseases. This association is primarily with the class II serologic specificities HLA-DR3 and -DQw2. We previously described a restriction fragment length polymorphism (RFLP) characterized by the presence of a 4.0-kilobase Rsa I fragment derived from an HLA class II beta-chain gene, which distinguishes the class II HLA haplotype of celiac disease patients from those of many serologically matched controls. We now report the isolation of this beta-chain gene from a bacteriophage genomic library constructed from the DNA of a celiac disease patient. Based on restriction mapping and differential hybridization with class II cDNA and oligonucleotide probes, this gene was identified as one encoding an HLA-DP beta chain. This celiac disease-associated HLA-DP beta-chain gene was flanked by HLA-DP alpha-chain genes and, therefore, was probably in its normal chromosomal location. The HLA-DP alpha-chain genes of celiac disease patients also were studied by RFLP analysis; 84% of HLA-DR3, -DQw2 patients had a 16-kb Xba I fragment that was present in only 36% of HLA-DR3, -DQw2 controls. Moreover, 79% of these patients had both alpha- and beta-chain polymorphisms in contrast to 27% of controls. Thus, celiac disease is associated with a subset of HLA-DR3, -DQw2 haplotypes characterized by HLA-DP alpha- and beta-chain gene RFLPs. Within the celiac-disease patient population, the joint segregation of these HLA-DP genes with those encoding the serologic specificities HLA-DR3 and -DQw2 indicates: (i) that the class II HLA haplotype associated with celiac disease is extended throughout the entire HLA-D region, and (ii) that celiac-disease susceptibility genes may reside as far centromeric on this haplotype as the HLA-DP subregion. FAU - Howell, M D AU - Howell MD AD - Department of Medicine, University of California, San Diego, La Jolla 92093. FAU - Smith, J R AU - Smith JR FAU - Austin, R K AU - Austin RK FAU - Kelleher, D AU - Kelleher D FAU - Nepom, G T AU - Nepom GT FAU - Volk, B AU - Volk B FAU - Kagnoff, M F AU - Kagnoff MF LA - eng GR - DK-35108/DK/NIDDK NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (HLA-D Antigens) RN - 0 (Macromolecular Substances) RN - 9007-49-2 (DNA) RN - EC 3.1.21.- (DNA Restriction Enzymes) SB - IM MH - B-Lymphocytes/immunology MH - Celiac Disease/genetics/*immunology MH - DNA/genetics MH - DNA Restriction Enzymes MH - HLA-D Antigens/*genetics MH - *Haplotypes MH - Humans MH - Macromolecular Substances MH - *Major Histocompatibility Complex MH - Nucleic Acid Hybridization MH - Polymorphism, Restriction Fragment Length MH - Reference Values PMC - PMC279516 EDAT- 1988/01/01 00:00 MHDA- 1988/01/01 00:01 PMCR- 1988/07/01 CRDT- 1988/01/01 00:00 PHST- 1988/01/01 00:00 [pubmed] PHST- 1988/01/01 00:01 [medline] PHST- 1988/01/01 00:00 [entrez] PHST- 1988/07/01 00:00 [pmc-release] AID - 10.1073/pnas.85.1.222 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1988 Jan;85(1):222-6. doi: 10.1073/pnas.85.1.222.